AIGISRx Preclinical Data

In Vivo Infectivity Models Demonstrating AIGISRx Efficacy† 

  • Control: Pacemaker Alone
  • Treatment Arm: Pacemaker + AIGISRx (minocycline and rifampin)

 

Rabbit Study1

Canine Study2

  

Additional information regarding the efficacy of the combination of minocycline and rifampin in reducing infections in medical devices can be found at "Antibiotics” under “ Our Technology. ” 


†AIGISRx reduction in infection is based on preclinical in vitro and in vivo data. Use of AIGISRx in contaminated wounds is not recommended. The device is not indicated for the treatment of infection.

 

Back to Top

  1. Data on file at TYRX, Efficacy Studies conducted at Wuxi Apptec, MN
  2. Data on file at TYRX, Canine study completed at Newark Beth Israel Hospital, Newark, NJ